Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays

Increasing evidence suggests that some newly emerged SARS-CoV-2 variants of concern (VoCs) resist neutralization by antibodies elicited by the early-pandemic wild-type virus. We applied neutralization tests to paired recoveree sera (n = 38) using clinical isolates representing the first wave (D614G)...

Descripción completa

Detalles Bibliográficos
Autores principales: Virtanen, Jenni, Uusitalo, Ruut, Korhonen, Essi M., Aaltonen, Kirsi, Smura, Teemu, Kuivanen, Suvi, Pakkanen, Sari H., Mero, Sointu, Patjas, Anu, Riekkinen, Marianna, Kantele, Anu, Nurmi, Visa, Hedman, Klaus, Hepojoki, Jussi, Sironen, Tarja, Huhtamo, Eili, Vapalahti, Olli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229637/
https://www.ncbi.nlm.nih.gov/pubmed/34073577
http://dx.doi.org/10.3390/v13060996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229637/
https://www.ncbi.nlm.nih.gov/pubmed/34073577
http://dx.doi.org/10.3390/v13060996

Ejemplares similares